Find Opioid & Heroin
Rehab Centers

The Opioid Crisis in America

Opioid use disorder (OUD) is the most deadly substance use crisis in American history. Opioids — including prescription pain medications (oxycodone, hydrocodone, fentanyl), heroin, and illicitly manufactured fentanyl — are responsible for more than 80,000 overdose deaths per year as of 2023. Illicit fentanyl, which is 50 to 100 times more potent than morphine, now contaminates much of the illegal drug supply, making any use potentially lethal.

OUD is a chronic brain disorder, not a moral failing. Repeated opioid use fundamentally changes the brain's reward, motivation, and stress systems — creating compulsive use patterns that are extraordinarily difficult to overcome with willpower alone. The neurological changes persist for months to years after stopping use, which is why relapse rates are high without evidence-based treatment. The good news: treatment works, and recovery is common.

MAT: The Gold Standard for Opioid Treatment

The most important advance in opioid addiction treatment is medication-assisted treatment (MAT). Despite persistent stigma, the science is unambiguous: MAT with buprenorphine or methadone is the most effective treatment for OUD available. It reduces overdose death risk by 50–65%, dramatically reduces illicit opioid use, decreases criminal activity, and improves physical health, mental health, and social functioning.

The National Institute on Drug Abuse, SAMHSA, the CDC, and ASAM all endorse MAT as the first-line treatment for OUD. People who receive MAT are significantly more likely to stay in treatment, less likely to relapse, and less likely to die from overdose than those who attempt abstinence without medication.

Methadone: The Long-Track Record

Methadone has been used for OUD treatment since the 1960s and has more than 50 years of research demonstrating its effectiveness. As a full opioid agonist, it eliminates withdrawal and cravings at therapeutic doses without producing euphoria. Research consistently shows methadone reduces heroin use, HIV transmission, criminal activity, and mortality.

Methadone for OUD can only be dispensed through federally licensed Opioid Treatment Programs (OTPs). Patients typically begin with daily clinic visits and earn take-home doses over time with demonstrated stability. OTPs also provide counseling and case management. Use RecoveryFinders to find licensed OTPs near you.

Buprenorphine (Suboxone): Office-Based Access

Buprenorphine is a partial opioid agonist available through doctors' offices, clinics, telehealth providers, and addiction treatment programs. The most common formulation is Suboxone (buprenorphine/naloxone film taken under the tongue). As of 2023, any DEA-registered prescriber can prescribe buprenorphine for OUD — expanding access dramatically. Primary care physicians, urgent care clinics, OB/GYN practices, and addiction specialists can all offer it.

Sublocade is a once-monthly injectable form of buprenorphine that eliminates the need for daily doses and is preferred by some patients for its convenience and consistent blood levels. Clinical trials show buprenorphine cuts overdose death rates in half among people with OUD.

Naltrexone (Vivitrol) for Opioid Addiction

Naltrexone is an opioid antagonist — it blocks opioid receptors completely. Available as a once-monthly injection (Vivitrol), it requires full detox before initiation. While it has lower retention rates than buprenorphine and methadone in most research, it is a valuable option for highly motivated individuals who have completed detox, and is commonly used in criminal justice settings.

Residential Treatment for Opioid Addiction

Inpatient residential rehab is appropriate for people with severe OUD, unstable housing, co-occurring mental health conditions, or a history of multiple relapses. The best residential programs for OUD integrate MAT with behavioral therapy rather than requiring abstinence from all medications. Programs that use medically supervised detox followed by immediate MAT initiation have significantly better retention and outcomes.